PathMDTM: Board Review Letter Blood Bank - Part 3
1. A Rh negative mother gives birth to a Rh positive son. Based on the information shown for case #1
on the website, how many vials of Rhogam should be given?
A. 3 vials B. 4 vials C. 5 vials D. 6 vials E. 7 vials
2. What is the maximum systolic blood pressure allowed to donate blood:
A. 200mm Hg B. 190mm Hg C. 180mm Hg D. 160mm Hg E. 100mm Hg
3. How long does a donor have to wait between whole blood donations:
A. 4 weeks B. 6 weeks C. 8 weeks D. 10 weeks E. No specific time as long as their Hb is > 12.5 g/dL
4. A donor should be deferred indefinitely for all of the following EXCEPT:
A. Family h/o Creutzfeldt-Jakob disease B. Receipt of plasma derived clotting factor concentrates C. History of viral hepatitis after 11th birthday D. Evidence of parenteral drug use E. Receipt of pituitary growth hormone of human origin
5. A donor indicates he is taking finasteride (Propecia, Proscar). He is informed that he will have to
wait one month from the last dose before he can donate blood. Which of the following also requires a one month delay from the last dose before an individual is eligible to donate blood?
A. Receipt of a killed vaccine B. Receipt of a live attenuated vaccine, Polio C. Etretinate (Tegison) D. Isotretinoin (Accutane) E. Bovine insulin manufactured in UK
6. All of the following are true with respect to anticoagulant / preservative solutions and storage in
A. Citrate-phosphate-dextrose (CPD) has a 21 day self life B. The addition of adenine (CPDA-1) to CPD lengthens the self life to 35 days C. Adding AS-1 (Adsol®) to CPD lengthens the self life to 42 days D. Frozen RBCs can be stored for 1 year at -65 C. E. Washed RBCs can be stored for 24 hrs. at 1-6 C after washing
PathMDTM: Board Review Letter Blood Bank - Part 3
7. Blood is regulated by which of the following:
A. American Association of Blood Banks (AABB) B. College of American Pathologists (CAP) C. Food and Drug Administration (FDA) D. Joint Commission on Accreditation of Healthcare Organizations (JCAHO) E. Clinical Laboratory Improvement Act (CLIA)
8. All of the following are true with regards to quality control for blood products EXCEPT:
A. Apheresis platelets >= 3 X 1010 platelets in 90% of tested units B. Random donor platelets >= 5.5 X 1010 platelets in 90% of tested units C. RBCs leukoreduced <= 5 X 106 WBCs in 95% D. RBCs
E. Granulocyte concentrate >= 1.0 X 1010 in 75% tested
9. In a patient who is not actively bleeding or hemolyzing, one unit of pRBCs can be expected to raise
A. 1 % B. 3 % C. 5 % D. 7 % E. None of the above
10. Blood can be transfused with which of the following:
A. Normal saline (0.9%) B. Lactated ringers C. 5% albumin D. Both A and C are correct E. All of the above are correct
Notes for question set:1
1 PathMD strives for the highest quality and accuracy. However, the PathMD: Board Review Letter is for review purposes and not meant for clinical decision making. It should not be used in place of review of primary reference texts and the current medical literature. If inaccuracies are identified, please notify us so that a correction may be published. ([email protected])
Complements of Researched Nutritionals (call 800 755 3402 or visit www.ResearchedNutritionals.com) Lyme Disease Diagnosis & Therapy Suggestions 2006 ACAM Meeting DIAGNOSIS AND THERAPY OF CHRONIC SYSTEMIC CO- INFECTIONS IN LYME DISEASE AND OTHER TICK-BORNE INFECTIOUS DISEASES The Institute for Molecular Medicine (Website www.immed.org) 16371 Gothard Street H, Huntin